Dopamine receptor stimulants in the treatment of alcoholism
Anokhina, I.P.; Ivanets, N.N.; Reshchikova, E.V.; Nebarakova, T.P.
Sovetskaia Meditsina 8: 93-95
1988
ISSN/ISBN: 0038-5077 PMID: 2904705 Document Number: 325627
Document emailed within 1 workday
Related Documents
Tanji, H.; Nagasawa, H.; Itoh, M.; Itoyama, Y. 1997: PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism Nihon Rinsho. Japanese Journal of Clinical Medicine 55(1): 89-94Hillegaart, V.; Ahlenius, S.; Fowler, C.J.; Magnusson, O. 1988: Increased duration of dopamine receptor antagonist-induced effects on both behaviour and striatal dopamine turnover by repeated testing in rats Pharmacology and Toxicology 63(2): 114-117
Sanger, G.J.; King, F.D. 1988: From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists Drug Design and Delivery 3(4): 273-295
Casellas, N.; Ferrani, A.; Cutillas, B.; Mahy, N. 1990: Characterization of D2-dopamine receptor modification in rat striatum after calcium channel blocker treatment Methods and Findings in Experimental and Clinical Pharmacology 12(9): 609-611
Li, G.-c.; Zhang, B.-l.; Xia, J.-y.; Fang, Z.-J. 2015: Synthesis and receptor binding assay of indolin-2-one derivatives as dopamine D4 receptor ligands Die Pharmazie 70(8): 511-514
van Vliet, B.J.; Mulder, A.H.; Schoffelmeer, A.N. 1990: Mu-opioid receptor-mediated inhibition of D-1 dopamine receptor stimulated adenylate cyclase in primary cultures of rat neostriatal neurons Progress in Clinical and Biological Research 328: 409-412
Gianoulakis, C. 1996: Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies Alcohol and Alcoholism . Suppl 31(1): 33-42
Saller, C.F.; Czupryna, M.J.; Salama, A.I. 1990: 5-HT2 receptor blockade by ICi 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade Journal of Pharmacology and Experimental Therapeutics 253(3): 1162-1170
Klicpera, C. 1978: Effects and side effect in the treatment of children with stimulants Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 46(7): 392-414
Arbuthnott, G.W.; Attree, T.J.; Eccleston, D.; Loose, R.W.; Martin, M.J. 1974: Is adenylate cyclase the dopamine receptor? Medical Biology 52(5): 350-353
DiPalma, J.R. 1990: Metoclopramide: a dopamine receptor antagonist American Family Physician 41(3): 919-924
Golden, R.N.; Miller, H.; Evans, D.L. 1989: Trimipramine and dopamine receptor blockade Journal of Clinical Psychiatry 50(10): 392-393
Kohli, J.D. 1990: Dopamine receptor agonists and antagonists Proceedings of the Western Pharmacology Society 33: 21-27
Kadzielawa, K. 1974: Dopamine receptor in the reward system of the rat Archives Internationales de Pharmacodynamie et de Therapie 209(2): 214-226
Nagy, J. 2004: Renaissance of NMDA receptor antagonists: do they have a role in the pharmacotherapy for alcoholism? Idrugs: the Investigational Drugs Journal 7(4): 339-350
Hvolby, A.; Jørgensen, J.Ib. 2004: Treatment with central nervous system stimulants. Practical guidelines Ugeskrift for Laeger 166(3): 144-148
Sokoloff, P.; Diaz, J.; Bordet, R.; Griffon, N.; Perachon, S.; Pilon, C.; Ridray, S.; Schwartz, J.C. 1998: Function and therapeutic potential of the dopamine D3 receptor Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 192(6): 1111-1125
Zhang, H.; Qiao, Z.; Zhao, Y.; Zhao, R. 1996: Transcription of dopamine D1A receptor mRNAs in rat heart Methods and Findings in Experimental and Clinical Pharmacology 18(3): 183-187
Santini, P.; Ceccanti, M.; De Lorenzo, A.; Pisculli, M.; Di Giovanni, M.G.; Cavaleri, G.; Attilia, M.L.; Berbellini, A. 1986: Ketanserin (S2-receptor blocking agent), platelet activity and chronic alcoholism International Journal of Clinical Pharmacology Research 6(1): 73-76
Osanai, S.; Akiba, Y.; Matsumoto, H.; Nakano, H.; Kikuchi, K. 1997: Effect of dopamine receptor on hypoxic ventilatory response Nihon Kyobu Shikkan Gakkai Zasshi 35(12): 1318-1323